William Cork Joins Fenwal as Chief Technology Officer

LAKE ZURICH, Illinois, November 10 - Fenwal Inc., a global medical technology company focused on improving
blood collection, separation, safety and availability, announced today
William H. Cork has joined the company as senior vice president and chief
technology officer. Mr. Cork, 50, will lead Fenwal's research and
development, regulatory and clinical affairs teams, reporting to Ron K.
Labrum, Fenwal's president and chief executive officer.

Mr. Cork joins Fenwal from Northbrook, Illinois-based Nanosphere Inc.
(Nasdaq: NSPH), where he was chief technology officer and vice president of
research and development since 2001. Nanosphere focuses on molecular
diagnostic testing.

Prior to this, Mr. Cork was vice president of research and development
for Fenwal (then a division of Baxter International), where he led the
development and global commercialization of platelet and cell-collection
technologies, including Fenwal's Amicus and CS-3000 separator portfolios.

"Bill is a strong and experienced scientific leader, with deep knowledge
of advanced molecular science, software development and transfusion medicine
with clinical relationships worldwide," Labrum said. "His decade-long tenure
with us in the 1990s was one of the most innovative and productive periods in
Fenwal's recent history."

Mr. Cork holds more than 15 medical-technology patents and has another
seven pending. He earned a bachelor's degree in electrical engineering from
Northwestern University, where he also minored in biomedical engineering. Mr.
Cork replaces Hiroshi Uchida as a member of Fenwal's executive team. Mr.
Uchida transitioned last month to Fenwal's board of directors.

Fenwal Inc. is a global medical technology company focused on improving
blood collection, separation, safety and availability for patient care.
Fenwal became an independent company in 2007, but its roots go back to 1949
with the founding of Fenwal Laboratories. Fenwal developed the first
flexible, disposable container for blood collection, eliminating
complications associated with glass containers and allowing blood to be
separated into therapeutic components. Today, the company's products and
advanced collection and separation technologies are used throughout the world
to help ensure a safe and available supply of lifesaving blood and blood
products. Fenwal Inc. is based in Lake Zurich, Illinois. For more
information, please visit www.fenwalinc.com.

Tanya Tyska of Fenwal Inc., +1-847-550-2732, tanya.tyska at fenwalinc.com